United States · Series A startup

Who invested in EdgeRunner AI

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AIHealthcare

Funding summaryUpdated 26 Oct 2026

$12Mraised across 1 round since 2025, from 1 source

Latest round
Series A, $12MMay 2025
Investors
2
See who backed them

The rounds

  1. May 2025
    Series A$12M

    Source recordedSEC filing: $12M sold, first sale Apr 2025

Founders and team

From EdgeRunner AI's own website: 2 founders, 2 on the team.

Tyler Xuan SaltsmanCo-Founder & CEO
Colton MalkersonCo-Founder & COO
  • Jack FitzGeraldChief Science Officer
  • Vincent LuChief Technology Officer

Everyone who backed them

Alumni VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists EdgeRunner AI as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

HP Tech VenturesCorporate VCPer its own site

Quick answers about EdgeRunner AI

Who invested in EdgeRunner AI?

EdgeRunner AI's investors include Alumni Ventures and Madrona Venture Group.

How much has EdgeRunner AI raised?

EdgeRunner AI has raised $12M across 1 round since 2025.

When did EdgeRunner AI last raise?

EdgeRunner AI's most recent round was a Series A of $12M in May 2025.

What was EdgeRunner AI's biggest round?

Its most recent round, $12M in May 2025, is also its largest on record.

Who backed EdgeRunner AI first?

EdgeRunner AI's first round on record, in May 2025, was backed by Alumni Ventures and Madrona Venture Group.

What stage is EdgeRunner AI at?

EdgeRunner AI's latest named round is a Series A, in May 2025.

Where is EdgeRunner AI based?

EdgeRunner AI is based in the United States.

Companies like EdgeRunner AI

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.